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1. Introduction 
Glycoproteins are increasingly being recognized as 
control or recognition processes in membrane- 
mediated events such as cell-cell agglutination, aggre- 
gation, adhesion, and ‘contact inhibition’ [ 11. In 
addition, a great many studies have measured glycosyl 
transferase activity in ‘neoplastic’ cells compared with 
‘normal’ cells, at times with conflicting outcomes 
[2-IO]. It seems clear, however, that in most cases 
of neoplastic transformation the cell or tissue change 
is accompanied by decreased elongation of certain 
glycolipids and increased or altered glycoprotein 
production [ Ill. 
Glycoprotein synthesis proceeds, in the main, by 
the independent sequential addition of individual 
monosaccharides to the polyribosome-released poly- 
peptide. These additions are catalyzed by glyco- 
protein:glycosyl transferases located predominantly 
in the cell’s Golgi apparatus but also to a small extent 
in the cell’s plasma membrane and mitochondria 
[ 1, 121. Glycoprotein:glycosyl transferases - e.g., 
iVacetylgalactosaminyl [ 131 and a sialyl (N-acetyl- 
neuraminic acid; NANA) [ 141 transferase - have also 
been found in the serum of humans and animals. The 
tissue source and physiological function of these 
soluble serum transferases are not completely known. 
It is of interest to speculate that the serum NANA 
transferase may be responsible for sialation of circu- 
lating glycoproteins with terminal galactosyl residues 
so that these glycoproteins are retained in the circula- 
tion and not cleared by the liver [ 151. 
This laboratory has reported [ 161 that human 
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breast tumor sialyl transferase activities were greatly 
elevated over the control, non-involved breast tissue 
level. In the present study we have investigated the 
activity of NANA transferase in serum from rats 
bearing two experimental breast tumors - the 
R3230AC transplantable mammary tumor and the 
7,12-dimethylbenz(a)anthracene (DMBA)-induced 
mammary tumor. We find, especially in the sera of 
rats bearing the R3230AC tumor, greatly elevated 
activity of serum NANA transferase; the magnitude 
of elevation is proportional to the tumor load in the 
R3230AC tumor-bearing animals. 
2. Materials and methods 
2.1. Materials 
Fetuin [ 171 was purchased from Grand Island 
Biological Co. Sialic acid-free fetuin was prepared as 
described previously [6]. CMP- [14 C] -N-acetyl- 
neuraminic acid (sialic 4,5,6,7,8,9-r4C; specific activ- 
ity 207 Ci/mole) was purchased from New England 
Nuclear Corporation. 
2.2. Tumor-bearing rats 
Female Fischer rats (approx. 80 g) were trans- 
planted subcutaneously bilaterally in the axillary 
region with the R3230AC mammary adenocarcinoma, 
using a sterile trochar technique described earlier 
[ 181. This isologous carcinoma, a slow-growing line 
arising from a spontaneous mammary tumor, has 
been classified as an autonomous, hormone-responsive 
tumor [ 191. At various times after tumor implanta- 
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tion, animals were killed by.cervical dislocation, and 
l-2 ml of whole blood was quickly obtained by 
cardiac puncture and placed in tubes on ice to allow 
clotting. Serum was obtained by centrifugation. In a 
few cases, lactating female rats from our breeding 
colony were killed, as above, and blood was obtained 
for analysis. Tumor weight in these animals after 
3 weeks of growth was 6-10 g (total) and after 
4 weeks of growth the tumor weighed between 8 and 
16 g. 
Serum was also obtained from a few animals 
(Sprague-Dawley female rats) bearing tumors induced 
by gastric intubation of 7,12_dimethylbenz(a)anthra- 
cene dissolved in sesame oil (5 mg/ml X 5 doses, 
1 dose per week). Animals were killed 9 weeks after 
the last intubation of carcinogen, at which time one 
animal had 5 tumors, one had 2 tumors, and one had 
one very small tumor. 
2.3. Complete system for ossay of fetuin:sialyl trans- 
ferase 
The complete system for assay of the fetuin:sialyl 
transferase contained 100 ~1 of the serum sample 
extract of the normal or tumor tissue (l-2 mg of 
protein), 50 ~1 of acceptor (fetuin minus sialic acid; 
approx. 300 c(g of protein), 10 11 of 0.1 M MnCl*, 
20 /..d of 0.1 M Tris buffer (pH 7.6), and 10 /.d of 
CMP- [ l4 C] NANA ( 10m9 mole), to a final volume of 
190 ~1. For experiments in the absence of added 
cation the 10plofO.l MMnClz and lOplof0.1 M 
MgClz were replaced with 20 ~1 of distilled water. 
This represented fetuin:sialyl or exogenous activity 
after subtraction of activity without acceptor present; 
for activity without added acceptor (i.e., activity 
with acceptors endogenous to the tissue), 50 ~1 of 
distilled water replaced the fetuin minus sialic acid in 
the assay mixture. After 30 min of incubation at 
37°C the radioactivity was determined as given else- 
where [2,4,6] _ The reaction was terminated with the 
addition of 1 .O% PTA in 0.1 N HCl, washed twice 
with 10% trichloroacetic acid, once with ethanol: 
diethyl ether (2: 1, v/v), and the resultant pellet (all 
acid insoluble materials were collected by centrifuga- 
tion) dissolved in 1 N NaOH and plated on a glass 
fiber filter; radioactivity was determined by liquid 
scintillation counting. Data are cpm per mg serum 
protein for 30 min incubation. Optimal conditions 
with respect to temperature, pH, and divalent cation 
concentration were met in the ‘plus cation’ system. 
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2.4. Protein 
Protein was determined by the method of Lowry 
et al. [20]. Bovine serum albumin was used as standard. 
There was no difference in protein per volume 
between the serum from the tumor-bearing and 
normal animals. 
3. Results and discussion 
Without added cation the normal rat serum had 
essentially the same activity of NANA transferase 
either in the presence or in the absence of added 
fetuin minus NANA (table 1). However, with added 
Mn2+ and Mg*+ the normal rat serum had about 
double the exogenous activity when fetuin minus 
NANA was added to the assay (table 2). 
The data of table 1 clearly indicate that (a) serum 
glycoprotein:NANA transferase activity was signi- 
ficantly elevated in the rats bearing the R3230AC 
tumor, (b) the elevation in the serum glycoprotein: 
NANA transferase activity was essentially proportio- 
nal to the load of tumor in the animal, and(c) interest- 
ingly, normal lactating animals had elevated serum 
glycoprotein:NANA transferase activity. 
Table 2 shows data for the optimized system with 
both Mn*+ and Mg*+ present in the serum NANA 
transferase assay. Similar conclusions can be made 
from these data as from the data of Table 1. In the 
serum from animals with 4-week R3230AC tumors, 
the fetuin:NANA transferase activity was 3894 cpm/ 
mg protein compared to 738 cpm/mg protein for the 
serum from control animals - a greater than 5fold 
increase in activity. 
In further experiments with the R3230AC tumor 
(not shown in the tables), we have in every instance 
been able to pick out the tumor-bearing rats (in blind 
studies) by levels of serum NANA transferase activ- 
ity; indeed in one instance a rat bearing 4-week 
R3230AC tumors was found to have a value of 6811 
cpm/mg protein in the ‘plus cation’ plus added fetuin 
minus NANA system. No false positives have been 
encountered - i.e., all values for control rat serum 
have been below those for R3230AC rat serum. 
Preliminary work with rats bearing DMBA-induced 
mammary tumors shows that serum NANA trans- 
ferases are also elevated in this system, but the dif- 
ferences from control values are not as striking or as 
consistent as with the transplanted R3230AC tumor 
(table 3). 
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Table 1 
Serum glycoprotein:NANA transferase activity in the absence of added 
cat on m normal rats and in rats bearing R3230AC tumors t 
Animals No. Activity (cpm/mg protein) 
Without added fetuin With added fetuin minus 
minus NANA NANA (endogenous activ- 
ity subtracted) 
Normal I 410 + 39 334 f 23 
2-week tumor 1 519 1184 
3-week tumor 4 616 * 83* 1370+ 113** 
4-week tumor 6 705 f 68** 1612+ 171** 
Lactating normal 3 354 f 37 699 * 82 
Experiments were performed as described in Materials and methods. Values are mean 
+ S.E.M. 
* Significantly different from normal, p < 0.05 (Student’s two-tailed test). 
** p < 0.01. 
Table 2 
Serum glycoprotein:NANA transferase activity in the presence of added 
cation in normal rats and in rats bearing R3230AC tumors 
Animal No. Activity (cpm/mg protein) 
Without added fetuin With added fetuin minus 
minus NANA NANA (endogenous activ- 
ity subtracted) 
Normal 7 393 + 45 738+60 
2-week tumor 1 423 1184 
3-week tumor 4 742 t Sl* 2850 fr 326* 
4-week tumor 6 720*67* 3894 f 153* 
Lactating normal 3 461 * 147 1664 + 165 
Experiments were performed as described in Materials and methods. Values are means 
f S.E.M. 
* Significantly different from normal, p < 0.01. 
Table 3 
Serum glycoprotein:NANA transferase activity in serum from rats with 
DMBA-induced tumors 
Tumor load Activity (cpm/mg protein) 
Without added fetuin minus With added fetuin minus 
NANA NANA 
Minus cation Plus cation Minus cation Plus cation 
system system system system 
- 
0 (control) 411 381 421 781 
10 mg 317 412 424 808 
18.5 g 506 396 810 1210 
23.0 g 746 789 1140 1867 
Experiments were performed as described in Materials and methods. 
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The data presented in this paper indicate that 
elevations in serum NANA:glycosyl transferase activ- 
ity accompany growth of mammary tumors in the 
rat, especially tumors of the transplantable.type. 
This suggests that during the neoplastic growth and 
invasion of these tumors, these enzymes ‘spill’ out of 
the tumor cells, leave the tumor site, and enter into 
the host’s circulation. Alternatively, the elevated sialyl 
transferase activity both in the tumor cell and in the 
serum may serve to initiate or sustain the neoplastic 
growth. Finally, if this phenomenon is similar to 
what happens in the human mammary tumor (H. B. 
Bosmann and T. C. Hall, work in progress), it may 
serve as a method of early or supportive diagnosis 
for human mammary malignancy. 
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